As predicted previously, (13th May) the OLO finger prick blood test device from Israel’s Sight Diagnostics flowed through the US FDA approval process.  It enables use of the CBC (Complete Blood Test) device in laboratories run by hospitals, diagnostic providers, and outpatient clinics.

https://www.timesofisrael.com/unlike-theranos-startups-blood-test-device-delivers-on-promise-with-fda-nod/